You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 7, July 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Impact of Neurologic Disease on Hospitalizations Related to Human Immunodeficiency Virus Infection in Maryland, 1991-1992

Gerald J. Dal Pan, MD, MHS; Richard L. Skolasky; Richard D. Moore, MD, MHS

Arch Neurol. 1997;54(7):846-852.


Abstract

Objectives
To determine the impact of neurologic disease on length of stay and total hospital charges for hospitalizations related to human immunodeficiency virus (HIV) infection.

Design
Review of all HIV-related hospitalizations from all acute nonfederal hospitals in Maryland in 1991 and 1992. Neurologic status and HIV disease status were determined by codes from the International Classification of Diseases, Ninth Revision, Clinical Modification, in an administrative database. Total hospital charges and length of stay were also included in this database.

Results
Of 12 128 HIV-related hospitalizations (6013 patients with the acquired immunodeficiency syndrome [AIDS], 308 HIV-seropositive patients with symptoms without AIDS, and 5807 HIV-seropositive patients without symptoms), neurologic disease occurred in 1013 (8.4%), predominantly in patients with AIDS. In all HIV-seropositive patients, those with primary neurologic disease had a longer mean (±SD) length of stay (16.4±16.5 days vs 9.3±11.3 days; P<.001) and higher mean (±SD) total charges ($12 733±$12009 vs $8069±$11 247; P<.001) than those without neurologic disease. In patients with AIDS, those with primary neurologic disease also had a longer mean (±SD) length of stay (17.2±17.2 days vs 11.7±12.7 days; P<.001) and higher mean (±SD) total charges ($13 430±$12 470 vs $10 794±$13 537; P<.001) than those without neurologic disease. After adjustment for age, sex, race, and stage of HIV infection in all HIV-seropositive patients, our results indicated that neurologic disease increased the length of stay by 3.3 days (95% confidence interval [CI], 2.9-3.8) and total charges by $2552 (95% CI, $2111-$2993). After adjustment for age, sex, and race in discharged patients with AIDS, the results showed that neurologic disease increased length of stay by 2.24 days (95% CI, 0.73-3.77) and total charges by $1512 (95% CI, $40-$2894).

Conclusion
Neurologic disease increases the length of stay and total hospital charges of HIV-infected patients.



Author Affiliations

From the Departments of Neurology (Dr Dal Pan and Mr Skolasky), Epidemiology (Dr Moore), and Medicine (Dr Moore), The Johns Hopkins University, Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.